Furthermore, the CREB inhibitor state-of-the-art is investigated extensively, including the histone lysine demethylases JMJD3/UTX inhibitor GSKJ4 that we newly identified as a promising CREB modulator in AML cells [16]. The gene discussed is KDM6B; the disease is acute myeloid leukemia.